Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             39 results found
no title author magazine year volume issue page(s) type
1 Cardiovascular risk and glucocorticoids: a Dutch National Registry of growth hormone treatment in adults with growth hormone deficiency analysis Slagboom, Tessa N. A.

27 5 p. 590-604
article
2 Cardiovascular risk in patients with acromegaly vs. non-functioning pituitary adenoma following pituitary surgery: an active-comparator cohort study Stocker, Melanie

27 5 p. 518-526
article
3 Clinical use of [18F]fluoro-ethyl-L-tyrosine PET co-registered with MRI for localizing prolactinoma remnants van Trigt, Victoria R.

27 5 p. 614-624
article
4 Clinicopathological analysis of non-functioning pituitary adenomas (PAs) according to the 2022 WHO classification Kim, Yeo Song

27 5 p. 665-672
article
5 Copeptin after pituitary surgery: is it worth measuring? Maffei, Pietro

27 5 p. 429-432
article
6 Correction: Development and validation of a novel treatment adherence, satisfaction and knowledge questionnaire (TASK-Q) for adult patients with hypothalamic-pituitary disorders Llahana, Sofia

27 5 p. 744
article
7 Correction: Utility of copeptin in predicting non-pathological postoperative polyuria in patients affected by acromegaly undergoing pituitary neurosurgery Varaldo, Emanuele

27 5 p. 742-743
article
8 Craniofacial impact of acromegaly: when muscle ma-sse-tter Cuny, Thomas

27 5 p. 437-439
article
9 Decreased β-cell volume and insulin secretion but preserved glucose tolerance in a growth hormone insensitive pig model Laane, Laeticia

27 5 p. 567-576
article
10 Desmopressin dose requirements in patients with permanent arginine vasopressin deficiency: a tertiary center experience Varaldo, Emanuele

27 5 p. 714-722
article
11 Development and validation of a novel treatment adherence, satisfaction and knowledge questionnaire (TASK-Q) for adult patients with hypothalamic-pituitary disorders Llahana, Sofia

27 5 p. 673-684
article
12 Diagnostic, therapeutic, and prognostic characteristics of patients with acromegaly according to tumor size at diagnosis Del Corso, Leticia Marinho

27 5 p. 537-544
article
13 Differential diagnosis between Cushing’s syndrome and non-neoplastic hypercortisolism: are we getting there? Pivonello, Rosario

27 5 p. 451-454
article
14 Does size really matter? A closer look at the absolute size of growth hormone-secreting pituitary adenomas Schilbach, Katharina

27 5 p. 440-443
article
15 Efficacy and safety of pasireotide treatment in acromegaly: A systematic review and single arm meta-analysis Aliyeva, Turkan

27 5 p. 468-479
article
16 GLP-1 receptor agonists may enhance the effects of desmopressin in individuals with AVP deficiency: a case series and proposed mechanism Nakhleh, Afif

27 5 p. 731-736
article
17 Glucose metabolism outcomes after pituitary surgery in patients with acromegaly Pascual-Corrales, Eider

27 5 p. 497-506
article
18 Growth hormone increase by luteinizing hormone-releasing hormone reflects gonadotroph-related characteristics in acromegaly Mitsui, Yuto

27 5 p. 527-536
article
19 Headache in patients with non-functioning pituitary adenoma before and after transsphenoidal surgery – a prospective study Hantelius, Victor

27 5 p. 635-643
article
20 “Intrasellar tumor-to-tumor metastasis: A single center experience with a systematic review” Mansur, Guilherme

27 5 p. 455-467
article
21 Is diabetes with acromegaly for life? Samson, Susan L.

27 5 p. 433-436
article
22 Is semaglutide a target therapy for acquired hypothalamic obesity? Prodam, Flavia

27 5 p. 444-448
article
23 Long-term metabolic effectiveness and safety of growth hormone replacement therapy in patients with adult growth hormone deficiency: a single-institution study in Japan Oi-Yo, Yuka

27 5 p. 605-613
article
24 Natural history of untreated microprolactinomas Sadek, Maryanne

27 5 p. 740-741
article
25 Neuroendocrine challenges and clinical outcomes in men with chronic traumatic brain injury: a cross-sectional study Zacharia, Saumya Susan

27 5 p. 693-704
article
26 Outcome of non-functioning ACTH pituitary tumors: silent does not mean indolent Sahakian, Nicolas

27 5 p. 644-653
article
27 Pituitary apoplexy: a comprehensive analysis of 93 cases across functioning and non-functioning pituitary adenomas from a single-center Ragate, Divya C.

27 5 p. 705-713
article
28 Recovery from hypogonadism in men with prolactinoma treated with dopamine agonists Constantinescu, Stefan Matei

27 5 p. 625-634
article
29 Semaglutide as a promising treatment for hypothalamic obesity: a six-month case series on four females with craniopharyngioma Gjersdal, Erlend

27 5 p. 723-730
article
30 Semaglutide treatment of hypothalamic obesity – a real-life data study Svendstrup, Mathilde

27 5 p. 685-692
article
31 Shared decision-making and detection of comorbidities in an online acromegaly consultation with and without the Acromegaly Disease Activity Tool ACRODAT® using the simulated person approach Friedel, Anna Lena

27 5 p. 545-554
article
32 Sleep disruption in patients with active and treated endogenous Cushing’s syndrome Geer, Eliza B.

27 5 p. 654-664
article
33 Somapacitan-induced reversible lipoatrophy in an adult woman with hypopituitarism Rakusa, Matej

27 5 p. 737-739
article
34 Temporal and masseter muscle evaluation by MRI provides information on muscle mass and quality in acromegaly patients Gatto, Federico

27 5 p. 507-517
article
35 The comprehensive evaluation of oral and fecal microbiota in patients with acromegaly Sahin, Serdar

27 5 p. 555-566
article
36 The diverging role of O-GlcNAc transferase in corticotroph and somatotroph adenomas Gonzalez, Roel

27 5 p. 577-589
article
37 The somatotroph pituitary gland function in high-aged multimorbid hospitalized patients with IGF-I deficiency Tausendfreund, Olivia

27 5 p. 480-487
article
38 Utility of copeptin in predicting non-pathological postoperative polyuria in patients affected by acromegaly undergoing pituitary neurosurgery Varaldo, Emanuele

27 5 p. 488-496
article
39 When to decide on testosterone replacement despite dopamine agonist therapy in male prolactinomas? Fukuoka, Hidenori

27 5 p. 449-450
article
                             39 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands